Skip to main content
Caplight Logo









Aston Sci. Inc.

Aston Sci. Inc.

Private
Hanam-siHealthcare & Life Scienceshttp://astonsci.com/

Last Round

Series D

Aug 20, 2026

Est. Valuation

$40.2M

Total Funding Raised

$81.4M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Aston Sci. Inc. is a clinical-stage biopharmaceutical company developing innovative medicines in oncology, immunology, and geriatrics, including therapeutic cancer vaccines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Application

Keywords

therapeutic cancer vaccinesclinical-stage biopharmaimmunotherapyoncologyAI drug discoverysolid tumorsdrug discoveryepitope discoverycancer recurrence preventionT-cell therapyprecision medicineInvestigational New DrugINDDNA vaccinespeptide vaccinesmRNA vaccinesproteostasis modulators

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aston Sci. Inc. Comparables

Compare Aston Sci. Inc. with similar companies based on industry and business-model similarity.

Aston Sci. Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anixa Biosciences, Inc.
80%
Gritstone bio
78%
IO Biotech
78%

Aston Sci. Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DAug 20, 2026
Series DApr 1, 2026
Series CDec 1, 2021
Series BNov 1, 2020
Series ANov 1, 2019

Key People

Founding team and executive leadership

Hun Jung

Chief Executive Officer

Executive Team

Aston Sci. Inc. Investors

Notable investors and investment history

Aston Sci. Inc. investors
InvestorRounds
ID VenturesSeries D
CKD Venture CapitalSeries D
Shinhan Venture InvestmentSeries C
Korea Investment PartnersSeries D
KB InvestmentSeries C
SBI Investment KoreaSeries D
Timefolio Asset ManagementSeries A, Series B, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    $28M round with participation from CKD Venture Capital and Kolon Investment.

  • Apr 1, 2026

    $13M round completed.

Aston Sci. Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aston Sci. Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aston Sci. Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHanam-si
Employee Range9
Year Founded2018
Last FundingAug 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?